Analyst Ratings For HCA Healthcare (NYSE:HCA)
Today, Argus raised its price target on HCA Healthcare (NYSE:HCA) to $114.00 per share.
Some recent analyst ratings include
- 2/1/2018-Sanford C. Bernstein Reiterated Rating of Market Perform.
Dividend information for HCA Healthcare (NYSE:HCA)
and an average dividend growth of 0.00% based on a 3 Year Average..
Recent Insider Trading Activity For HCA Healthcare (NYSE:HCA)
HCA Healthcare (NYSE:HCA) has insider ownership of 2.90% and institutional ownership of 75.49%.
- On 2/9/2018 Michael S Cuffe, Insider, sold 8,335 with an average share price of $97.26 per share and the total transaction amounting to $810,662.10.
- On 2/6/2018 Sandra L Morgan, SVP, sold 3,698 with an average share price of $96.91 per share and the total transaction amounting to $358,373.18.
- On 2/2/2018 Ravi S. Chari, SVP, sold 16,270 with an average share price of $101.73 per share and the total transaction amounting to $1,655,147.10.
- On 2/1/2018 Bill B Rutherford, CFO, sold 48,462 with an average share price of $102.42 per share and the total transaction amounting to $4,963,478.04.
- On 2/1/2018 Charles J Hall, Insider, sold 35,949 with an average share price of $103.09 per share and the total transaction amounting to $3,705,982.41.
- On 1/31/2018 Jonathan B Perlin, CMO, sold 23,005 with an average share price of $101.55 per share and the total transaction amounting to $2,336,157.75.
- On 1/31/2018 Samuel N Hazen, COO, sold 56,000 with an average share price of $100.47 per share and the total transaction amounting to $5,626,320.00.
Recent Trading Activity for HCA Healthcare (NYSE:HCA)
Shares of HCA Healthcare closed the previous trading session at 97.85 up +0.06 0.07% with shares trading hands.